Catheter Precision

Catheter Precision Current Assets

The Current Assets of Catheter Precision (VTAK) as of Oct 17, 2026 is 235,000.00 USD. In the previous year, Current Assets was 3.29 M USD — a change of -92.86% (lower).

Current Assets

235,000.00USD

YoY

-92.86%

Last updated:

Current Assets of Catheter Precision is 2025 235,000.00 USD. Current Assets of Catheter Precision was 2024 3.29 M USD. It decreases by -92.86% lower compared to the previous year.

The Catheter Precision Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
67.91 M USD
Jan 1, 2019
35.21 M USD
Jan 1, 2020
27.62 M USD
Jan 1, 2021
17.09 M USD
Jan 1, 2022
16.89 M USD
Jan 1, 2023
4.16 M USD
Jan 1, 2024
3.29 M USD
Jan 1, 2025
235,000.00 USD
The Catheter Precision Current Assets history
YEARCurrent AssetsYoY
235,000.00USD-92.86%
3.29 MUSD-20.88%
4.16 MUSD-75.36%
16.89 MUSD-1.17%
17.09 MUSD-38.13%
27.62 MUSD-21.57%
35.21 MUSD-48.15%
67.91 MUSD+613.00%
9.53 MUSD+93.79%
4.91 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Catheter Precision Stock analysis

What does Catheter Precision do? Catheter Precision Inc, trading under the ticker VTAK, is a US-based health care company headquartered in Fort Mill. The company has 14 employees and went public via an IPO on September 27, 2018. Its website is https://www.ramed.com/. Catheter Precision Inc operates within the health care sector, focusing on medical technology solutions. The company's product portfolio includes the Amigo remote catheter system, which features an open architecture design allowing for use in additional catheter procedures. It also offers the VIVO non-invasive three-dimensional imaging system, designed to help physicians identify the origin of arrhythmias before procedures, thereby streamlining workflow and reducing procedure time. Additionally, the company develops the LockeT suture retention device. Catheter Precision Inc is engaged in developing technologies for electrophysiology procedures, collaborating with physicians to advance its product offerings. The company aims to improve treatment outcomes for patients with cardiac arrhythmias through its medical technologies. Its focus is on providing solutions that enhance the efficiency and effectiveness of cardiac arrhythmia treatments in clinical settings. The company's products are intended for use by hospitals, physicians, and patients seeking improved care for cardiac conditions. The firm's operations are centered on innovation in electrophysiology, with an emphasis on creating tools that support better patient outcomes and more efficient medical procedures. Catheter Precision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Catheter Precision stock

Current Assets of Catheter Precision is 235,000.00 USD in 2025.

Current Assets of Catheter Precision changed from 3.29 M USD to 235,000.00 USD, representing a -92.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Catheter Precision since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Catheter Precision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Catheter Precision

All Key Metrics — Catheter Precision